BRPI1008743A2 - Processo para o preparo de olopatadina e/ou um sal farmacêuticamente aceitável da mesma. - Google Patents

Processo para o preparo de olopatadina e/ou um sal farmacêuticamente aceitável da mesma.

Info

Publication number
BRPI1008743A2
BRPI1008743A2 BRPI1008743-5A BRPI1008743A BRPI1008743A2 BR PI1008743 A2 BRPI1008743 A2 BR PI1008743A2 BR PI1008743 A BRPI1008743 A BR PI1008743A BR PI1008743 A2 BRPI1008743 A2 BR PI1008743A2
Authority
BR
Brazil
Prior art keywords
pharmaceutically acceptable
acceptable salt
preparing olopatadine
olopatadine
preparing
Prior art date
Application number
BRPI1008743-5A
Other languages
English (en)
Inventor
Alberto Guidi
Gianmauro Orru
Massimo Verzini
Livius Cotarca
Jean-Claude Kizirian
Elisenda Trepat Guixer
Francisco Marquillas Olondriz
Original Assignee
Zach System Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zach System Spa filed Critical Zach System Spa
Publication of BRPI1008743A2 publication Critical patent/BRPI1008743A2/pt
Publication of BRPI1008743A8 publication Critical patent/BRPI1008743A8/pt
Publication of BRPI1008743B1 publication Critical patent/BRPI1008743B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/12—[b,e]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BRPI1008743-5A 2009-02-05 2010-02-01 Processo para o preparo de olopatadina BRPI1008743B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09152194.8 2009-02-05
EP09152194 2009-02-05
PCT/EP2010/051148 WO2010089268A2 (en) 2009-02-05 2010-02-01 Process for preparing olopatadine and/or a pharmaceutically acceptable salt thereof

Publications (3)

Publication Number Publication Date
BRPI1008743A2 true BRPI1008743A2 (pt) 2015-09-01
BRPI1008743A8 BRPI1008743A8 (pt) 2017-07-11
BRPI1008743B1 BRPI1008743B1 (pt) 2021-09-08

Family

ID=42109900

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1008743-5A BRPI1008743B1 (pt) 2009-02-05 2010-02-01 Processo para o preparo de olopatadina

Country Status (14)

Country Link
US (1) US8835655B2 (pt)
EP (1) EP2393797B1 (pt)
JP (1) JP5564060B2 (pt)
CN (1) CN102292326B (pt)
AU (1) AU2010211085B2 (pt)
BR (1) BRPI1008743B1 (pt)
CA (1) CA2746331C (pt)
ES (1) ES2581833T3 (pt)
HR (1) HRP20160567T1 (pt)
HU (1) HUE028705T2 (pt)
IL (1) IL213364A (pt)
PL (1) PL2393797T3 (pt)
SI (1) SI2393797T1 (pt)
WO (1) WO2010089268A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9562030B2 (en) 2013-03-19 2017-02-07 Council Of Scientific And Industrial Research Process for the synthesis of olopatadine
CN106117176B (zh) * 2016-06-24 2018-12-11 四川大学 二氢双苯并恶庚衍生物及其组合物与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282365A (en) 1978-11-24 1981-08-04 Merck & Co., Inc. Dibenz[b,e]oxepin compounds
EP0069810B1 (en) 1981-07-09 1986-12-03 Merck & Co. Inc. Novel dibenzoxepins, their preparation, compositions containing them and the use of dibenzoxepins in the treatment of allergic conditions
GB8520662D0 (en) * 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
WO2006004757A2 (en) 2004-06-28 2006-01-12 Alcon, Inc. Topical formulations for treating allergic diseases
ES2253996B1 (es) 2004-07-28 2007-08-16 Urquima, S.A. Procedimiento para la preparacion del acido 11-((z)-3-(dimetilamino)propiliden)-6,11-dihidrodibenz(b,e)oxepinacetico.
EP2228371A1 (en) 2005-12-22 2010-09-15 Medichem, S.A. New process for preparing olopatadine free base and/or its hydrochloride salt
US7687646B2 (en) 2006-03-28 2010-03-30 Azad Pharmaceutical Ingredients, Ag Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof

Also Published As

Publication number Publication date
HUE028705T2 (en) 2016-12-28
BRPI1008743B1 (pt) 2021-09-08
CA2746331C (en) 2016-09-06
JP5564060B2 (ja) 2014-07-30
CN102292326A (zh) 2011-12-21
JP2012516869A (ja) 2012-07-26
WO2010089268A2 (en) 2010-08-12
ES2581833T3 (es) 2016-09-07
WO2010089268A3 (en) 2010-10-14
PL2393797T3 (pl) 2016-12-30
US20120016138A1 (en) 2012-01-19
EP2393797B1 (en) 2016-04-20
IL213364A (en) 2016-06-30
BRPI1008743A8 (pt) 2017-07-11
AU2010211085B2 (en) 2016-08-25
AU2010211085A1 (en) 2011-07-07
EP2393797A2 (en) 2011-12-14
SI2393797T1 (sl) 2016-07-29
IL213364A0 (en) 2011-07-31
US8835655B2 (en) 2014-09-16
CN102292326B (zh) 2015-04-22
HRP20160567T1 (hr) 2016-07-01
CA2746331A1 (en) 2010-08-12

Similar Documents

Publication Publication Date Title
NO2020006I1 (no) upadacitinib or a pharmaceutically acceptable salt thereof
NO2022033I1 (no) Rimegepant or a pharmaceutically acceptable salt thereof
NO2023047I1 (no) Cedazuridine, or a pharmaceutically acceptable salt thereof
NO2020038I1 (no) Ozanimod, or a pharmaceutically acceptable salt thereof, including the hydrochloride salt
BRPI0910734A2 (pt) composto, composição farmacêutica, e, processo para preparar um composto ou um sal farmaceuticamente aceitável do mesmo.
NO2015012I1 (no) Ombitasvir, eller et farmasøytisk akseptabelt salt derav
NL300886I2 (nl) baricitinib, of een farmaceutisch aanvaardbaar zout daarvan
BRPI0919018A2 (pt) sal farmaceuticamente aceitável, uso de sal, e, processo para a preparação de sal
NO2016016I1 (no) Lesinurad, eller et farmasøytisk akseptabelt salt derav
BRPI1013561A8 (pt) processo para a preparação de alogliptina
BRPI0918038A2 (pt) Processos para preparar um composto e um sal, e, composto
BRPI1014606A2 (pt) Maltotriosil transferase, processo para produção e uso da mesma
BRPI0813903A2 (pt) Processos para a prepração de pirazóis
BRPI1004574A2 (pt) pastilha de corte com fornecimento de refrigerante e método para a elaboração da pastilha de corte
BRPI1014547A2 (pt) composto, e, processo para preparar um composto.
NO2023002I1 (no) Lasmiditan or a pharmaceutically acceptable salt thereof
BRPI0923007A2 (pt) Sal de piperazina e um processo para preparação do mesmo
BRPI1013032A2 (pt) "película de barreira resistente às intempéries, processo para a produção desta e uso da mesma"
BRPI0922836A2 (pt) processo para a preparação de um sal de succinato monovalente
BRPI1010300A2 (pt) processos para a preparação de um composto, para perparar dronedarone, ou um sal do mesmo, e para preparar uma formulação farmacêutica.
BRPI1014691A2 (pt) Composto, e, processo para a preparação de um composto.
BR112012001462A2 (pt) processo para preparar metil mercaptano.
BRPI0924566A2 (pt) sistema para cirurgia oftálmica a laser
BRPI1009816A2 (pt) "método para preparar um composto."
BRPI1015089A2 (pt) nifuratel ou um sal fisiologicamente aceitável do mesmo.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. (IT)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: C07D 313/12

Ipc: C07D 313/12 (2006.01), A61P 11/02 (2006.01), A61P

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B09X Republication of the decision to grant [chapter 9.1.3 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/02/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.